LingLing Fu (Hao Gu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Atrial Fibrillation

Prognostic Factors

Ejection Fraction

Top Venues

DNA and cell biology

International journal of immunopathology and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Xingjuan Xie, LingLing Fu, Jingyao Ma, Lingling Fu, Jie Ma, Jialu Zhang, Runhui Wu, Zhenping Chen
FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia. DNA and cell biology 43 (6) (2024)
Xingjuan Xie, LingLing Fu, Jingyao Ma, Lingling Fu, Jie Ma, Jialu Zhang, Runhui Wu, Zhenping Chen
FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia. DNA and cell biology 43 (6) (2024)
Xingjuan Xie, LingLing Fu, Jingyao Ma, Lingling Fu, Jie Ma, Jialu Zhang, Runhui Wu, Zhenping Chen
FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia. DNA and cell biology (2024)
LingLing Fu, Zhenping Chen, Jie Ma, Jing Wang, Rui Zhang, Runhui Wu, Tianyou Wang
Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD. International journal of immunopathology and pharmacology 35 (2022)
Jiafeng Yao, LingLing Fu, Wenjun Mou, Zhenping Chen, Jie Ma, Honghao Ma, Nan Li, Rui Zhang, Tianyou Wang, Jin Jiang, Runhui Wu
Various phenotypes of LRBA gene with compound heterozygous variation: A case series report of pediatric cytopenia patients. International journal of immunopathology and pharmacology 36 (2022)
Xiaoling Cheng, LingLing Fu, Jing-Yao Ma, Lingling Fu, Zhenping Chen, Li-Bo Zhao, Xiaoling Wang, Runhui Wu
Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice. Blood advances 5 (19) (2021)